Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05982119 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 20, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Laurent Servais to Centre Hospitalier Universitaire de Liege
    • Site contacts updated at 1 of 8 sites
    v5
  2. Study sites: 1 to 8v4
  3. Enrollment target: 130 to 300
    • Interventions: ActiMyo (Device) to ActiMyo/Syde (Device)
    • Eligibility criteria expanded, about 156 words
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the ActiLiège Next study is to collect longitudinal data from patients and control subjects using a wearable magneto-inertial device. By collecting natural history data in various neuromuscular disorders (Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy 1, Charcot-Marie-Tooth, Centronuclear Myopathy, Congenital Muscular Dystrophy), we aim to validate digital outcome measures to continuously assess motor function in real-life.
Trial Details
NCT Number NCT05982119
Lead Sponsor Centre Hospitalier Universitaire de Liege
Collaborators: SYSNAV
Conditions
(from sponsor)		 Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy 1, Charcot-Marie-Tooth, Centronuclear Myopathy, Congenital Muscular Dystrophy
Related terms Charcot-Marie-Tooth Disease, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Facioscapulohumeral, Myopathies, Structural, Congenital, Myotonic Dystrophy
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov